Status
Acquired by MacroGenics on July 17, 2008
Funding Received
$48.3 Million in 1 Round from 12 Investors
Founded:
1999
Headquarters:
South San Francisco, CA
Description:
Raven biotechnologies is focused on the development of monoclonal antibody therapeutics for the treatment of cancer.
Founders:
Jennie P. Mather
Categories:
Biotechnology

Detailed Description

Update

Raven biotechnologies, Inc., a biotechnology company, focuses on the development of monoclonal antibody therapeutics for treating cancer. Its lead product candidate, RAV12, targets adenocarcinomas and used for the treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is based in South San Francisco, California. As of July 17, 2008, Raven Biotechnologies, Inc. operates as a subsidiary of MacroGenics, Inc.

Past Team (2)

Update

Investors (12)

Update

Offices/Locations (1)

Update
  • Office

    One Corporate Drive

    South San Francisco, CA 94080

    USA